SXTP.NASDAQ60 Degrees Pharmaceuticals, INC

SCHEDULE: Investment Firms Disclose 9.9% Stake in 60 Degrees Pharma

Sentiment:

Beneficial Ownership Disclosure 7 November 2025 4:54 PM

📋All filings for 60 Degrees Pharmaceuticals, INC

CVI Investments and Heights Capital Management report a 9.9% beneficial ownership in 60 Degrees Pharmaceuticals, primarily through warrants.

Capital raiseThe beneficial ownership reported consists of shares issuable upon the exercise of warrants to purchase common stock.The exercise of these warrants would result in the issuance of new shares, potentially increasing the company's capital.The warrants are subject to a 9.99% beneficial ownership limitation, restricting the immediate full exercise if it would exceed this threshold.

Summary

CVI Investments, Inc. and Heights Capital Management, Inc. (Reporting Persons) have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in 60 Degrees Pharmaceuticals, Inc.
The filing discloses beneficial ownership of 455,545 shares of Common Stock in 60 Degrees Pharmaceuticals, Inc.
This ownership represents 9.9% of the company's outstanding common stock.
The beneficially owned shares consist of shares issuable upon the exercise of warrants to purchase Common Stock.
The warrants are subject to a 9.99% beneficial ownership limitation, meaning the Reporting Persons cannot exercise them to the extent that their total beneficial ownership would exceed this threshold.
Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc., and as such, may exercise shared voting and dispositive power over the reported shares.
As of September 3, 2025, 60 Degrees Pharmaceuticals, Inc. had 4,104,469 shares of Common Stock outstanding.

Sentiment

Score: 5

Explanation: This is a neutral, factual disclosure of beneficial ownership, not containing performance or forward-looking statements that would significantly sway sentiment.

Positives

A significant institutional investment of 9.9% by CVI Investments, Inc. and Heights Capital Management, Inc. indicates a notable level of confidence in 60 Degrees Pharmaceuticals, Inc.

Risks

The warrants held by the Reporting Persons are not exercisable to the extent that beneficial ownership would exceed 9.99%, which could limit their ability to increase their stake beyond this threshold.

Future Outlook

Industry Context

Stakeholder Impact

Shareholders: The disclosure of a significant institutional stake (9.9%) by CVI Investments and Heights Capital Management could be viewed positively, signaling institutional confidence. The existence of warrants could lead to future dilution if exercised, but also provides potential capital to the company.

Key Dates

Date	Description
2024-07-12	Date of Prospectus referenced in the Prospectus Supplement.
2025-09-03	Date as of which 4,104,469 shares of Common Stock were outstanding.
2025-09-05	Date of filing of the Company's Prospectus Supplement (Registration No. 333-280796).
2025-09-30	Date of event which requires filing of this statement.
2025-11-06	Date of signing and filing of this Schedule 13G Amendment No. 1.

Keywords

60 Degrees Pharmaceuticals, CVI Investments, Heights Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Institutional Investment, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.